Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada

IMPORTANCE: The risk of myocarditis or pericarditis after COVID-19 messenger RNA vaccines varies by age and sex, and there is some evidence to suggest increasing risk with shorter intervals between dose 1 and 2 (ie, interdose interval). OBJECTIVE: To estimate the incidence of reported myocarditis or...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchan, Sarah A., Alley, Sarah, Seo, Chi Yon, Johnson, Caitlin, Kwong, Jeffrey C., Nasreen, Sharifa, Thampi, Nisha, Lu, Diane, Harris, Tara M., Calzavara, Andrew, Wilson, Sarah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972235/
https://www.ncbi.nlm.nih.gov/pubmed/36848096
http://dx.doi.org/10.1001/jamapediatrics.2022.6166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972235/
https://www.ncbi.nlm.nih.gov/pubmed/36848096
http://dx.doi.org/10.1001/jamapediatrics.2022.6166

Ejemplares similares